The HFD + CCl4 group had an evident rise of the expression and activation of GRP78, PERK, EIF2α and NFκB in rats’ livers compared to the HFD group, suggesting that low-dose CCl4 could aggravate ERS in NAFLD rats. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.